Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

KalVista meets main goals in late-stage trial for skin condition treatment

Feb 13 (Reuters) - KalVista Pharmaceuticals  KALV.O 
said on Tuesday its therapy for a type of skin condition met the
main goals in a late-stage trial.

 (Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Kalvista Pharmaceuticals

See all news